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SLX4 interactswith several endonucleases to resolve
structural barriers in DNA metabolism. SLX4 also in-
teracts with telomeric protein TRF2 in human cells.
The molecular mechanism of these interactions at
telomeres remains unknown. Here, we report the
crystal structure of the TRF2-binding motif of SLX4
(SLX4TBM) in complex with the TRFH domain of
TRF2 (TRF2TRFH) and map the interactions of SLX4
with endonucleases SLX1, XPF, and MUS81. TRF2
recognizes a unique HxLxP motif on SLX4 via the
peptide-binding site in its TRFH domain. Telomeric
localization of SLX4 and associated nucleases
depend on the SLX4-endonuclease and SLX4-TRF2
interactions and the protein levels of SLX4 and
TRF2. SLX4 assembles an endonuclease toolkit
that negatively regulates telomere length via SLX1-
catalyzed nucleolytic resolution of telomere DNA
structures.We propose that the SLX4-TRF2 complex
serves as a double-layer scaffold bridging multiple
endonucleases with telomeres for recombination-
based telomere maintenance.
INTRODUCTION
Telomeres are highly conserved chromosome end structures,
composed of the shelterin protein complex and a double-
stranded tract of tandem repeats that ends in a single-stranded
30-overhang of the G-strand in mammals (Blackburn, 2001). The
30 single-stranded overhang has been proposed to invade theCelduplex region of telomeric DNAs, base-pairing with the C-strand,
forming a ‘‘t-loop’’ configuration (Griffith et al., 1999). Shelterin
consists of several proteins including duplex telomeric DNA-
binding proteins TRF1 and TRF2 that anchor shelterin along
the telomere repeats (Palm and de Lange, 2008). TRF1 and
TRF2 are also the principle mediators that recruit many nonshel-
terin telomere accessory proteins including Apollo (Palm and de
Lange, 2008) to telomeres (Palm and de Lange, 2008). The telo-
mere restriction fragment homology (TRFH) domains of TRF1
and TRF2 (Li et al., 2000) directly recognize specific but distinct
motifs on their interacting proteins (Chen et al., 2008).
A critical aspect of telomere maintenance is telomere length
homeostasis, involving telomerase-catalyzed extension and
alternative lengthening of telomeres (ALT). In addition, TRF1
and TRF2 are negative regulators of telomere length (Ancelin
et al., 2002; Smogorzewska et al., 2000; van Steensel and de
Lange, 1997). Although TRF1 is believed to regulate telomerase
in cis at individual telomeres, TRF2 may control telomere length
by telomere degradation (Ancelin et al., 2002). Homologous-
recombination (HR)-mediated resolution of t-loop has also
been proposed to be the underlying mechanism for a negative
telomere length regulation process, referred to as ‘‘telomere
trimming’’ (Pickett et al., 2009; Wang et al., 2004), which leads
to deletion of large telomeric segments that are detectable as
extrachromosomal telomeric circles (TCs) (Pickett et al., 2009,
2011; Wang et al., 2004). Some cancer cells maintaining telo-
mere length via ALT exhibit abundant TCs (Henson and Reddel,
2010) and likely utilize telomere trimming to counteract HR-
mediated telomere lengthening (Cesare and Reddel, 2010).
Yet, the regulatory mechanism for telomere trimming is not fully
understood.
A Fanconi anemia (FA) protein, SLX4 (or BTBD12 or FANCP), is
a molecular scaffold that interacts with structure-specificl Reports 4, 861–869, September 12, 2013 ª2013 The Authors 861
endonucleases XPF-ERCC1, MUS81-EME1, and SLX1 (Fekairi
et al., 2009; Kim et al., 2013; Mun˜oz et al., 2009; Svendsen
et al., 2009). SLX4 also associates with TRF2 in human cells
(Svendsen et al., 2009). However, the nature of this interaction
and the functional significance of SLX4 at telomeres remain
unknown. Here, we report that telomeric localization of SLX4
and its associated nucleases depends on the interaction
between a unique HxLxP motif of SLX4 and the TRFH domain
of TRF2. We propose that SLX4 together with TRF2 forms a
double-layer scaffold that assembles a telomere maintenance
toolkit, containing XPF, MUS81, and SLX1, where the SLX4-
SLX1 module regulates telomere length via SLX1-catalyzed
resolution of telomeric DNA structures.
RESULTS
Telomeric Localization of SLX4 Depends on Protein
Levels of SLX4 and TRF2
To investigate the involvement of SLX4 in telomeremaintenance,
we examined telomeric localization of endogenous SLX4 in
different human cell lines, including telomerase-negative ALT
cells (U2OS,WI38[VA13-2RA], andGM847), telomerase-positive
cancer cells (HT1080, HeLa, and its subclone HeLa1.2.11), and
primary cells (BJ and MRC5). Indirect immunofluorescence (IF)
showed that SLX4 formed discrete nuclear foci in all of these
cells (Figures 1A and S1A; data not shown). Unlike the primary
(BJ) and telomerase-positive (HT1080 and HeLa) cancer cells,
themajority of the SLX4 foci in ALT andHeLa1.2.11 cells colocal-
ized with TRF2 and telomeres (Figures 1A and S1A). The associ-
ation of SLX4 with telomeres in U2OS and HeLa1.2.11 cells was
also confirmed by chromatin immunoprecipitation (ChIP) (Fig-
ure S1B). Because telomeres in ALT cells are substantially longer
than those in other cells and HeLa1.2.11 cells possess longer
telomeres than its parental HeLa cells (Figure 1B), we reasoned
that SLX4may preferentially localize to longer telomeres. Indeed,
SLX4 increasingly localized to telomeres in telomerase-positive
cells with longer telomeres (Figures 1C and 1D; Supplemental
Information). Notably, the few telomeres in the ALT (U2OS) cells
that did not colocalize with SLX4 foci also exhibited substantially
weaker signals than the majority of SLX4-overlapping telomeres
(Figure 1E), further suggesting that SLX4 tends to be targeted to
longer telomeres. The amount of SLX4 at individual telomeres
was also dependent on the protein levels of SLX4 and TRF2 (Fig-
ures 1F and S1C; Supplemental Information), which inmany cells
positively correlate with longer telomere length.
A Short Motif on SLX4 Mediates the SLX4-TRF2
Interaction Essential for Telomeric Localization of SLX4
TRF2 interacts with the middle region of SLX4 (Svendsen et al.,
2009). We found that SLX4 binds to the TRFH domain of TRF2
(TRF2TRFH) by yeast two-hybrid (Y2H) assay (data not shown).
Various fragments of SLX4 were evaluated for their ability to
interact with TRF2TRFH by Y2H and isothermal titration calorim-
etry (ITC) assays (Figures S2A–S2E). A short fragment of SLX4
consisting of residues 1014–1028 (SLX41014-1028) was sufficient
for binding with TRF2TRFH with a KD of 750 nM (Figures 2A and
2B), whereas binding enthalpy between SLX41014-1028 and
TRF1TRFH was not measurable by ITC (Figure S2F), indicating862 Cell Reports 4, 861–869, September 12, 2013 ª2013 The Authorthat SLX41014-1028 binding is specific for TRF2.We hereafter refer
to SLX41014-1028 as SLX4TBM (TRF2-binding motif) (Figure 2A).
We have demonstrated that TRF2TRFH specifically recognizes
a short peptide motif with a signature sequence YxLxP (x: any
amino acid) on its interacting proteins including Apollo (Chen
et al., 2008). SLX4TBM contains amodified sequence HxLxP (Fig-
ure 2A) that highly resembles the TRF2TRFH binding motif of
Apollo (ApolloTBM) (Figure 2A) (Chen et al., 2008), suggesting
that SLX4TBM might bind to TRF2TRFH in the same fashion as
ApolloTBM. We solved the crystal structure of the TRF2TRFH-
SLX4TBM complex at 2.05 A˚ resolution (Figure S2G; Table S1).
The structure exhibits a 2:2 stoichiometry between TRF2TRFH
and SLX4TBM. Each SLX4TBM peptide adopts an extended
conformation with a short one-turn helix at the N terminus and
fits into the narrow groove formed by TRF2TRFH (Figure 2C).
Except for the very N terminus, SLX4TBM and ApolloTBM are iden-
tical in overall conformation (Figure 2D). Two key hydrophobic
residues in SLX4TBM, L1022, and P1024 bind to TRF2TRFH in
the same fashion as do their counterparts in ApolloTBM. The imid-
azole ring of SLX4 H1020 occupies the same position as the side
chain of Apollo Y504 in the ApolloTBM-TRF2TRFH complex (Fig-
ure 2D) (Chen et al., 2008).
To investigate the importance of the interface residues of
SLX4TBM or TRF2TRFH in the SLX4-TRF2 interaction, we focused
on four hydrophobic residues: F120 of TRF2 and H1020, L1022,
andP1024of SLX4,whoseequivalents in otherTRF2TRFH-binding
proteins are critical for their respective interactions (Chen et al.,
2008). ITC data showed that alanine substitutions of these resi-
dues either completely abolished (SLX4 L1022A and TRF2
F120A) or substantially impaired (SLX4 H1020A and P1024A)
the SLX4-TRF2 interaction (Figures 2E, S2H, and S2I). Consistent
with the ITC analysis, coimmunoprecipitation (co-IP) revealed
that while SLX4L1022A and TRF2F120A completely disrupted the
association between SLX4 and TRF2, mutations of SLX4 H1020
and P1024 to alanine retained weak interactions with TRF2 in
human embryonic kidney 293T cells (Figure 2F). Furthermore,
SLX4L1022A was efficiently coimmunoprecipitated with MUS81
(Figure 2F) that is known to bind to the C-terminal region of
SLX4 (Fekairi et al., 2009; Kim et al., 2013; Svendsen et al.,
2009). Hence, the observed SLX4-TRF2 interface is specific and
necessary for both in vitro and in vivo binding of SLX4 to TRF2.
We tested the relevance of the SLX4-TRF2 interaction to the
telomeric localization of SLX4 in U2OS and HeLa1.2.11 cells
transiently expressing wild-type (WT) or mutant GFP-SLX4
fusion protein and HA-tagged WT or mutant TRF2. IF analysis
revealed a nuclear punctate staining pattern for WT SLX4
that almost completely colocalized with TRF2 (Figures 2G and
S2J–S2L). In contrast, the SLX4L120A and TRF2F120Amutants dis-
rupted the colocalization of SLX4 and TRF2 (Figures 2G and
S2J–S2L). As both WT TRF2 and TRF2F120A mutant can effi-
ciently localize to telomeres (Figures 2G and S2J–S2L), these re-
sults demonstrate that SLX4 binding to TRF2TRFH is required for
telomeric localization of SLX4.
Nuclear Foci Formation and Telomeric Localization of
XPF, MUS81, and SLX1 Are Mediated by SLX4
SLX4 contains modules that interact with other protein factors,
including XPF, MUS81, and SLX1 (Fekairi et al., 2009; Kims
Figure 1. Association of SLX4 with Telomeres Is Dependent on Proteins Levels of SLX4 and/or TRF2
(A) Endogenous SLX4 and TRF2 colocalization in human cells. Bar: 5 mm.
(B) Telomere length in different human cell lines by TRF analysis.
(C) Percentage of SLX4 foci at telomeres in HeLa and HeLa1.2.11 cells. One hundred cells/genotype were examined. p value: two-tailed Student’s test.
(D) Telomeric localization of SLX4 in primary human fibroblasts inducedwith hTERT and hTR (long telomeres: HSF-P35; short telomeres: HSF-P7). Error bars: SD;
p values: two-tailed Student’s t test.
(E) Signal intensity of SLX4-nonoverlapping or -overlapping telomeres. Error bars: SD. p values: two-tailed Student’s t test.
(F) Percentage of SLX4 foci at telomeres in HeLa and HT1080 cells transfected with SLX4 and/or TRF2. Error bars: SD; p values: two-tailed Student’s t test.
See also Figure S1.et al., 2013; Mun˜oz et al., 2009; Svendsen et al., 2009). Using
Y2H assay, we mapped three nonoverlapping fragments of
SLX4 that interact with XPF, MUS81, and SLX1 (Figures 3A
and S3A–S3C), hereafter referred to as XBR (XPF-binding re-
gion), MBR (MUS81-binding region), and SBR (SLX1-binding re-
gion), respectively (Figure 3A). Co-IP showed that the deletion
mutants of SLX4 (SLX4DXBR, SLX4DMBR, and SLX4DSBR), each
lacking only the specific interacting region for one endonuclease,Celspecifically abolished only the targeted interaction in cells (Fig-
ure 3B). Furthermore, IF analysis demonstrated that nuclear
foci formation of XPF, MUS81, and SLX1 relied on their specific
interactions with SLX4 (Figures 3C and S3D–S3F; Supplemental
Information).
Because TRF2 bridges SLX4 with telomeres, we tested
whether the SLX4-TRF2 interaction is critical for telomeric local-
ization of the SLX4-interacting nucleases. We utilized either thel Reports 4, 861–869, September 12, 2013 ª2013 The Authors 863
Figure 2. The SLX4-TRF2 Interaction Is Crit-
ical for Telomeric Localization of SLX4
(A) Sequence comparison between SLX4TBM and
ApolloTBM. Key residues that mediate the interac-
tion with TRF2TRFH are highlighted in red.
(B) ITC measurement of the SLX4TBM-TRF2TRFH
interaction. Inset shows the ITC titration.
(C) Overall structure of the SLX4TBM-TRF2TRFH
complex. TRF2TRFH and SLX4TBM are colored in
green and yellow, respectively, in one monomer,
and dark green and orange, respectively, in the
other.
(D) Superposition of the TBM peptide-binding
sites in the SLX4TBM-TRF2TRFH and ApolloTBM-
TRF2TRFH complexes. TRF2TRFH is colored in
purple and green in the SLX4TBM-TRF2TRFH and
ApolloTBM-TRF2TRFH complexes, respectively.
(E) Equilibrium dissociation constants (Kd) of WT
and mutant SLX4TBM-TRF2TRFH interactions
measured by ITC. N.D., not detectable.
(F) Co-IP of WT and mutant SLX4 and TRF2 in
293T cells. Lanes marked ‘‘IN’’ contain 5% of the
input lysate used for IPs.
(G) Nuclear localization of WT and mutant SLX4
and TRF2. Telomeric DNA was detected by the
Cy3-labeled (CCCTAA)3 PNA probe. Bar: 5 mm.
See also Figure S2.SLX4L1022A or the TRF2F120A mutant, each of which can indepen-
dently abolish the SLX4-TRF2 interaction (Figures 2E–2G and
S2H–S2L), and individually expressed each endonuclease with
SLX4L1022A (Figures 3E and S3G) or TRF2F120A (data not shown)
and assayed their nuclear localization. Although XPF, MUS81,
and SLX1 formed discrete foci that colocalized with SLX4L1022A,
they failed to be targeted to telomeres (Figures 3E and S3G).
Also, all three nucleases failed to colocalize with TRF2F120A
(data not shown). Hence, SLX4 functions as a scaffold to target
XPF, MUS81, and SLX1 to telomeres via its interaction with
TRF2.
SLX4 Mediates Its Affiliated Nucleases in Regulating
Telomere Recombination
MUS81 has been shown to regulate T-SCE in human ALT cells
(Zeng et al., 2009). Because the telomeric localization of
MUS81 depends on SLX4 (Figure 3C), we asked whether SLX4
is required for telomere recombination. We depleted SLX4 in
U2OS cells using small hairpin RNA (shRNA) (Figures S4A–
S4C) and analyzed T-SCE by chromosome orientation (CO) fluo-
rescence in situ hybridization (FISH) (Figures S4D and S4E).
Whereas U2OS cells exhibited 0.2 T-SCEs/chromosome,
depletion of SLX4 decreased the frequency to 0.04 T-SCEs/
chromosome (Figure S4F), underscoring the importance of864 Cell Reports 4, 861–869, September 12, 2013 ª2013 The AuthorsSLX4 in T-SCE. Expression of WT SLX4
(Figure S4C) elevated the level of T-
SCEs to 0.45 T-SCEs/chromosome,
thereby rescuing the defect in T-SCE
caused by SLX4 depletion (Figure S4G).
In contrast, expression of the TRF2-bind-
ing-deficient SLX4L1022A (Figure S4C)failed to fully promote T-SCE (Figure S4G), suggesting that telo-
meric localization of SLX4 is crucial for T-SCE.
Because XPF, MUS81, and SLX1 are recruited to telomeres by
SLX4, we examined the role of each of these endonucleases in
T-SCE by expressing SLX4DXBR, SLX4DMBR, or SLX4DSBR dele-
tion mutants in SLX4-depleted U2OS cells (Figure S4C). None
of these mutants was able to rescue the T-SCE defects due to
SLX4 depletion (Figure S4G), indicating that all three endonucle-
ases are required for T-SCE in U2OS cells. Similar results were
also observed in HeLa1.2.11 cells (Figure S4H). Thus, SLX4 reg-
ulates telomere recombination, which is dependent on the SLX4-
TRF2 scaffold and also on the nucleases XPF, MUS81, and
SLX1.
SLX4 Negatively Regulates Telomere Length via
Association with SLX1
In mammalian cells, telomere length is maintained at or near an
equilibrium point. Because SLX4 is preferentially detected at
longer telomeres and interacts with nucleases in human cells
(Figures 1 and 3), we investigated the role of SLX4 and its asso-
ciated nucleases in telomere length regulation. U2OS cells stably
expressing SLX4 shRNA were transiently transfected with either
empty GFP vector or GFP-fused WT or mutant SLX4 and subse-
quently analyzed for telomere length using quantitative FISH
Figure 3. SLX4 Serves as a Scaffold to Assemble a Nuclease Toolkit at Telomeres
(A) Domain organization of SLX4 and its interacting proteins. The shaded areas between SLX4 and its interacting proteins indicate the regions of the respective
protein-protein interactions. B, basic domain.
(B) Co-IP confirmation of SLX4-nuclease interacting regions. Lanes marked ‘‘IN’’ contain 5% of the input lysate used for IPs. Asterisk: nonspecific band.
(C and D) IF analysis of foci formation and colocalization of the nucleases in SLX4-depleted U2OS cells expressing WT or deletion mutants of SLX4 that either
disrupt (C) or preserve (D) the respective interactions.
(E) IF-telomere FISH analysis of foci formation and colocalization of the nucleases with telomeric DNA in SLX4-depletedU2OS cells expressingWTSLX4 or TRF2-
binding-deficient mutant SLX4L1022A.
See also Figure S3.(Q-FISH) analysis. SLX4-depleted cells (vec) exhibited a 2-fold
increase in telomere length in comparison to the control cells
(Scramble) (Figures 4A, S5A, and S5B), indicating that SLX4 is
a negative regulator of telomere length. Telomere length was
quickly restored to the levels of control cells, 24–48 hr after
expression of WT SLX4 (Figure 4A). This suggests that the telo-
mere lengthening in SLX4-depleted cells is attributable to SLX4Celdeficiency. Expression of the TRF2-binding-deficient mutant
SLX4L1022A could not restore telomere length in SLX4-depleted
cells to that of control cells (Figure 4A), underscoring the impor-
tance of TRF2-mediated telomeric localization of SLX4 in telo-
mere length regulation. Interestingly SLX4DSBR failed to rescue
the telomere length defect due to SLX4 depletion, whereas
SLX4DXBR or SLX4DMBR-expressing cells exhibited normal or al Reports 4, 861–869, September 12, 2013 ª2013 The Authors 865
Figure 4. The SLX4-SLX1 Nuclease Complex Regulates Telomere Length and T-Loop Resolution
(A and B) Telomere length in SLX4-depleted U2OS cells expressing WT or mutant SLX4 (A) or WT SLX4 fused to WT or nuclease dead (E82A) mutant of SLX1 (B).
Mean telomere length was derived from three independent experiments. NS, nonsignificance. p values: one-way ANOVA.
(C) Plasmid-based D-loop assay in the presence of purified SLX1-SLX4SBR complex.
(legend continued on next page)
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slightly longer average length than those in control cells
(Scramble) (Figure 4A). These results support that, among the
three endonucleases, SLX1 is essential for telomere length regu-
lation in human cells.
To examine whether SLX1 regulates telomere length by nucle-
olytic cleavage of telomere DNAs, we utilized the nuclease-defi-
cient E82A mutant of SLX1 (SLX1E82A). Because SLX1 is neither
stable nor active without SLX4 (Svendsen et al., 2009), we gener-
ated chimeric constructs expressing WT or E82A SLX1 fused to
SLX4, referred to as SLX4-SLX1WT or SLX4-SLX1E82A. Expres-
sion of SLX4-SLX1WT in SLX4-depleted U2OS cells caused a
marked reduction in telomere length as compared to the control
cells (vec). In sharp contrast, expression of SLX4-SLX1E82A had
no effect on telomere length (Figure 4B). Similar results were
observed in HeLa1.2.11 cells (Figure S5C). These data suggest
that the nuclease activity of the SLX4-SLX1 complex plays an
important role in telomere length maintenance in human cells.
The SLX4-SLX1 Complex Provides Nuclease Activity for
T-Loop Resolution
Negative regulation of telomere length in human cells might
involve a highly controlled process called ‘‘telomere trimming’’
via nucleolytic resolution of t-loops, leading to formation of
TCs (Pickett et al., 2009, 2011; Wang et al., 2004). The SLX4-
SLX1 complex displays robust resolution activity towards HJ
substrates in vitro (Fekairi et al., 2009;Mun˜oz et al., 2009; Svend-
sen et al., 2009) and might mediate negative regulation of telo-
mere length by catalyzing nucleolytic resolution of the t-loop.
We first employed a plasmid-based D-loop assay (Verdun and
Karlseder, 2006) to examine whether SLX4-SLX1 is capable of
resolving D-loop, an intrinsic part of a t-loop, in vitro. In this
assay, we relied on the requisite protein factors in nuclear extract
to form a D-loop in the presence of a telomeric-repeat-contain-
ing plasmid (pSxNeo540-T2AG3) and a radiolabeled telomeric
probe, with or without purified recombinant full-length SLX1 in
complex with the C-terminal SBR domain of SLX4 (SLX1-
SLX4SBR) (Figure 4C). With increasing amount of the SLX1WT-
SLX4SBR complex, the radioactive signal corresponding to the
D-loop significantly decreased in intensity, with concomitant in-
crease in free probe intensity, suggesting that the SLX1-SLX4
complex antagonizes or impedes D-loop formation in vitro (Fig-
ures 4D and 4E). In contrast, D-loop or free probe signal was
unaltered when the catalytically deficient mutant SLX1E82A-
SLX4SBR complex was added in the assay, even at themaximum(D and E) Agarose gel (D) and quantification (E) showing SLX1WT-SLX4SBR comp
free probe. For each reaction, the D-loop and free probe signal were normalized to
Lane 1 in (D) denotes the control without telomere repeat-containing plasmid. Er
(F) The oligonucleotide-based telomeric D-loop substrate. The invading strand (IS
sites by the SLX1-SLX4SBR nuclease complex.
(G and H) The telomeric D-loop substrate was incubated with increasing amounts
products are indicated on native (G) or denaturing (H) gel. Symbols DS (lane 1): he
amount of the WT enzyme complex, followed by heat denaturation.
(I) TCA assay in SLX4-depleted U2OS cells, transiently expressing vector, WT, or m
was set for 100%.
(J and K) The SLX4-SLX1 complex is a player in TRF2-mediated telomere shorten
TRF2 alone (J) or together with SLX4WT or SLX4DSBR (K). Mean telomere len
nonsignificance. p values: one-way ANOVA.
See also Figure S5.
Celconcentration (Figures 4D and 4E). Thus, the endonuclease ac-
tivity of SLX1 is likely instrumental in thwarting D-loop formation.
To gain better mechanistic insight into D-loop resolution by the
SLX1-SLX4 complex, we generated a model immobile telomeric
D-loop structure in vitro, assembled from oligonucleotides (Fig-
ure 4F) (Opresko et al., 2004). A 67-mer invading strand (IS)
that mimics the 30-telomeric overhang was radiolabeled at the
50 end and hybridized with the melted region of a duplex DNA
to form a telomeric D-loop structure. Increasing amounts of the
SLX1WT-SLX4SBR complex resulted in disappearance of the
D-loop substrate and the appearance of three bands (denoted
by a, b, c), migrating below the D-loop on a native gel (Figure 4G,
lanes 3–6, and Figure S5D). Bands ‘‘b’’ and ‘‘c’’ correspond to
the digested and released products of the IS (Figure 4G,
compare lanes 3–6 with 11), whereas band ‘‘a’’ very likely repre-
sents a partially resolved D-loop that remains associated with
the intact IS, formation of which requires nucleolytic cleavage
by SLX1, as implied from the absence of this band in the
nuclease dead mutant (Figure 4G, compare lanes 3–6 with
7–10). The two cleavage products (b and c) were also visualized
by a denaturing gel and are approximately 24-mer and 6-mer in
length, respectively (Figure 4H, lanes 2–5). Significantly, in vivo, a
nucleolytic cut on the invading 30-telomeric overhang would pre-
dictably result in resolution of the t-loop structure. In contrast,
the D-loop substrate was completely resistant to the catalytically
deficient SLX1E82A-SLX4SBR mutant complex (Figure 4G, lanes
7–10, Figure 4H, lanes 6–9, and Figure S5D). These data support
that the endonuclease activity of SLX1 is necessary for the
cleavage and release of the IS and hence for proper resolution
of the D-loop structure in vitro.
We reasoned that, if the SLX1-SLX4 complex nucleolytically
resolves D-loops in vitro, this might translate into enhanced TC
formation in vivo. We analyzed TC formation in U2OS cells
depleted of SLX4 by employing a F29 DNA-polymerase-depen-
dent T-circle amplification (TCA) assay (Figures 4I and S5E)
(Zellinger et al., 2007). A substantial decrease in TC formation
was observed in SLX4-depleted cells (Figure 4I, shSLX4-1), as
compared to control shRNA-treated cells (scramble), suggestive
of the importance of SLX4 in TC biogenesis in human cells. TC
formation was nearly completely rescued by WT SLX4 but not
the SLX1-binding-deficient mutant SLX4DSBR (Figure 4I), further
supporting that SLX1 plays an important role in the generation
of TCs. We also observed that expression of the TRF2-bind-
ing-deficient mutant SLX4L1022A in SLX4-depleted U2OS cellslex-dependent change in radioactive signals corresponding to the D-loop and
the reactions containing no (0 ng) andmaximum enzyme (200 ng), respectively.
ror bars denote variations from three independent experiments.
) was labeled with [32P]-g-ATP at the 50 end (in red). Arrows: possible cleavage
of the SLX1WT-SLX4SBR or SLX1E82A-SLX4SBR complexes. The IS and cleavage
at denatured substrate alone. DE (lane 11): substrate incubated with maximum
utant SLX4. The TC signal was normalized to the scramble control (lane 2) that
ing. Q-FISH analysis of telomere length in U2OS cells expressing WT or mutant
gth was derived from three independent experiments. Error Bars: SD. NS,
l Reports 4, 861–869, September 12, 2013 ª2013 The Authors 867
failed to rescue TC-formation to control levels, underscoring the
importance of SLX4-TRF2 interaction in SLX1-dependent TC
formation and is consistent with the colocalization data that
targeting SLX1 to telomeres is dependent on the SLX4 and
TRF2 interaction (Figure 3E).
TRF2-Mediated Telomere Shortening Relies upon the
SLX4-SLX1 Complex
Expression of TRF2 causes rapid loss of telomeres in ALT cells
(Figure 4J) (Ancelin et al., 2002). Of note, overexpression of the
TRF2F120A mutant did not alter telomere length (Figure 4J), sug-
gesting that factors that bind to the TRFH peptide-binding site of
TRF2 contribute to telomere shortening. Because SLX4 interacts
with TRF2 via the TRFH peptide-binding site and depletion of
SLX4 leads to telomere lengthening (Figure 4A), SLX4 might be
required for TRF2-mediated telomere shortening in ALT cells.
U2OS cells were cotransfected with mCherry-fused WT TRF2
and GFP-fused WT SLX4 or the SLX1-binding-deficient mutant
SLX4DSBR. Cells positive for GFP and mCherry signals were
analyzed for telomere length by Q-FISH. Coexpression of
TRF2 and SLX4 led to rapid telomere loss (Figures 4K). In
contrast, coexpressing TRF2 and SLX4DSBR had no detectable
effect on telomere length (Figures 4K and S5F). A similar result
was also observed in HeLa1.2.11 cells (Figure S5G). Thus,
TRF2-mediated rapid telomere shortening requires SLX1 that
is recruited to telomeres via SLX4.
For additional details, see the Extended Results.
DISCUSSION
In this report, we provide structural, molecular, and cellular evi-
dence that SLX4 through its interaction with TRF2 functions as
a ‘‘double-layer scaffold’’ to organize a multinuclease ‘‘telomere
maintenance’’ toolkit. Assembly of this toolkit requires the SLX4-
TRF2 interaction and three nonoverlapping motifs of SLX4 (XBR,
MBR, and SBR) to recruit endonucleases XPF, MUS81, and
SLX1, respectively, to the SLX4 foci. An advantage of this ‘‘dou-
ble-layer’’ scaffold is that it can more efficiently recruit multiple
proteins simultaneously to telomeres with fixed stoichiometry
than a ‘‘single-layer’’ architecture in which all factors would be
recruited by interactions with TRF2 alone. Another advantage
is that SLX4 may function not only as the binding platform for
the endonucleases, but also as a coordinator, orchestrating
complicated processes at telomeres in a regulated manner.
Given that all three endonucleases are required for proper
T-SCE and that each nuclease exhibits different in vitro substrate
preference (Fekairi et al., 2009; Mun˜oz et al., 2009; Svendsen
et al., 2009), it is likely that T-SCE requires activities of all three
nucleases, coordinated by SLX4. In fact, it has been proposed
that resolution of HJs in vivo by the SLX4-nuclease complex
may require SLX1 to first create a nicked intermediate that is
then acted upon by MUS81 (Svendsen et al., 2009).
TRF1 and yeast telomeric protein Rap1 function as cis-acting
negative regulators of telomere length (Bianchi and Shore, 2008;
van Steensel and de Lange, 1997). TRF2 is also a negative regu-
lator of telomere length and its expression causes rapid loss of
telomeres in human ALT cells (Ancelin et al., 2002). Here, we un-
veil the SLX4-SLX1 nuclease complex assembled on telomeres868 Cell Reports 4, 861–869, September 12, 2013 ª2013 The Authoras a player in TRF2-mediated negative telomere length regula-
tion in cis and propose the following model (Figure S5H). TRF2
binds to telomeric DNA and functions as a measuring device to
assess telomere length. Longer telomeres are bound by larger
amount of TRF2, which subsequently recruits more SLX4 to telo-
meres. The double-layered SLX4-TRF2 platform then assembles
a nuclease toolkit at telomeres for HR-mediated telomere
recombination, including T-SCE and t-loop resolution. Nuclease
SLX1 catalyzes nucleolytic cleavage of telomere DNA and leads
to ‘‘telomere trimming.’’We speculate that the telomere trimming
process would continue until telomeres no longer bind sufficient
TRF2 and hence the SLX4-SLX1 complex. We propose that
SLX4-TRF2-assembled nuclease toolkit helps maintain an
average equilibrium telomere length thus preventing telomere
overlengthening. Our study reveals a major difference between
TRF1 and TRF2 cis-acting mechanisms of telomere length
regulation. Although TRF1 regulates telomere length via inhibit-
ing telomerase activity, TRF2 recruits endonucleases via SLX4
to regulate telomere length. Because SLX4-TRF2-dependent
telomere shortening occurs in both HeLa1.2.11 and ALT cells,
nucleolytic cleavage of telomere DNAs by the SLX4-nuclease
complex may be one of the common telomere length homeosta-
sis mechanisms employed at long telomeres.
EXPERIMENTAL PROCEDURES
Protein Expression, Purification, Crystallization, and Structure
Determination
Proteins were expressed in E. coli BL21(DE3) or B834(DE3). Human TRF2TRFH
(residues 42–245), TRF1TRFH (residues 65–267), and SLX4TBM (residues 1014–
1028), were purified by Ni-NTA (QIAGEN) metal affinity, followed by gel-filtra-
tion chromatography. The SLX1WT or E82A-SLX4SBR complexes were purified
by tandem affinity steps (Ni-NTA and glutathione Sepharose), followed by
gel filtration. Crystals of the SLX4TBM-TRF2TRFH complex were grown by
sitting-drop vapor diffusion at 4C. Structure of the TRF2TRFH-SLX4TBM com-
plex was solved by molecular replacement.
Telomere Detection Assays
Q-FISH (Zijlmans et al., 1997) or CO-FISH (Bailey et al., 2004) were used to
measure telomere length and T-SCE, respectively. For IF-telomere FISH, cells
were stained with primary and subsequently Alexa-Fluor-labeled secondary
antibodies, followed by fixation and telomere-FISH (Wang et al., 2010). TCA
(Zellinger et al., 2007) was used to detect telomere circles. Plasmid (Verdun
and Karlseder, 2006) or oligonucleotide-based (Opresko et al., 2004) assays
were used to detect D-loop resolution.
For additional details, see the Extended Experimental Procedures.
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